336 related articles for article (PubMed ID: 31566126)
1. Current RNA-based Therapeutics in Clinical Trials.
Zhou LY; Qin Z; Zhu YH; He ZY; Xu T
Curr Gene Ther; 2019; 19(3):172-196. PubMed ID: 31566126
[TBL] [Abstract][Full Text] [Related]
2. RNA-based therapeutics: current progress and future prospects.
Burnett JC; Rossi JJ
Chem Biol; 2012 Jan; 19(1):60-71. PubMed ID: 22284355
[TBL] [Abstract][Full Text] [Related]
3. Next-generation therapeutics for rare genetic disorders.
Sankar A; Y S RK; Singh A; Roy R; Shukla R; Verma B
Mutagenesis; 2024 Apr; 39(3):157-171. PubMed ID: 38332115
[TBL] [Abstract][Full Text] [Related]
4. Progress on RNA-based therapeutics for genetic diseases.
Luo T; Huo C; Zhou T; Xie S
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 52(4):406-416. PubMed ID: 37643975
[TBL] [Abstract][Full Text] [Related]
5. Nucleic acid-based techniques for post-transcriptional regulation of molecular targets.
Jarad G; Simske JS; Sedor JR; Schelling JR
Curr Opin Nephrol Hypertens; 2003 Jul; 12(4):415-21. PubMed ID: 12815338
[TBL] [Abstract][Full Text] [Related]
6. The notorious R.N.A. in the spotlight - drug or target for the treatment of disease.
Reautschnig P; Vogel P; Stafforst T
RNA Biol; 2017 May; 14(5):651-668. PubMed ID: 27415589
[TBL] [Abstract][Full Text] [Related]
7. Antisense technologies in the studying of Toxoplasma gondii.
Crater AK; Roscoe S; Roberts M; Ananvoranich S
J Microbiol Methods; 2017 Jul; 138():93-99. PubMed ID: 26724749
[TBL] [Abstract][Full Text] [Related]
8. RNA Therapeutics: the Next Generation of Drugs for Cardiovascular Diseases.
Bejar N; Tat TT; Kiss DL
Curr Atheroscler Rep; 2022 May; 24(5):307-321. PubMed ID: 35364795
[TBL] [Abstract][Full Text] [Related]
9. Antitumoral RNA-targeted oligonucleotide therapeutics: The third pillar after small molecule inhibitors and antibodies.
Taniguchi H; Suzuki Y; Imai K; Adachi Y
Cancer Sci; 2022 Sep; 113(9):2952-2961. PubMed ID: 35701833
[TBL] [Abstract][Full Text] [Related]
10. RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges.
Yu AM; Choi YH; Tu MJ
Pharmacol Rev; 2020 Oct; 72(4):862-898. PubMed ID: 32929000
[TBL] [Abstract][Full Text] [Related]
11. Noncoding oligonucleotides: the belle of the ball in gene therapy.
Shum KT; Rossi JJ
Adv Genet; 2015; 89():153-177. PubMed ID: 25620011
[TBL] [Abstract][Full Text] [Related]
12. RNA Therapeutics: How Far Have We Gone?
Coutinho MF; Matos L; Santos JI; Alves S
Adv Exp Med Biol; 2019; 1157():133-177. PubMed ID: 31342441
[TBL] [Abstract][Full Text] [Related]
13. The Clinical Potential of Oligonucleotide Therapeutics against Pancreatic Cancer.
Takakura K; Kawamura A; Torisu Y; Koido S; Yahagi N; Saruta M
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284594
[TBL] [Abstract][Full Text] [Related]
14. DNA-based therapeutics and DNA delivery systems: a comprehensive review.
Patil SD; Rhodes DG; Burgess DJ
AAPS J; 2005 Apr; 7(1):E61-77. PubMed ID: 16146351
[TBL] [Abstract][Full Text] [Related]
15. Advances in the delivery of RNA therapeutics: from concept to clinical reality.
Kaczmarek JC; Kowalski PS; Anderson DG
Genome Med; 2017 Jun; 9(1):60. PubMed ID: 28655327
[TBL] [Abstract][Full Text] [Related]
16. From bench side to clinic: Potential and challenges of RNA vaccines and therapeutics in infectious diseases.
Pandey M; Ojha D; Bansal S; Rode AB; Chawla G
Mol Aspects Med; 2021 Oct; 81():101003. PubMed ID: 34332771
[TBL] [Abstract][Full Text] [Related]
17. Ribozymes as therapeutic tools for genetic disease.
Phylactou LA; Kilpatrick MW; Wood MJ
Hum Mol Genet; 1998; 7(10):1649-53. PubMed ID: 9735387
[TBL] [Abstract][Full Text] [Related]
18. Small Interfering RNAs and RNA Therapeutics in Cardiovascular Diseases.
Bansal P; Arora M
Adv Exp Med Biol; 2020; 1229():369-381. PubMed ID: 32285425
[TBL] [Abstract][Full Text] [Related]
19. [Oligonucleotide therapeutics - an emerging novel class of compounds].
Wacheck V
Wien Med Wochenschr; 2006 Sep; 156(17-18):481-7. PubMed ID: 17041803
[TBL] [Abstract][Full Text] [Related]
20. Antisense technologies. Improvement through novel chemical modifications.
Kurreck J
Eur J Biochem; 2003 Apr; 270(8):1628-44. PubMed ID: 12694176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
